Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs... see more

TSX:TH - Post Discussion

Theratechnologies Inc > Building anticipation to achieve an optimal result
View:
Post by SPCEO1 on Feb 09, 2022 10:52am

Building anticipation to achieve an optimal result

On the presumption that there is something noteworthy in the phase 1a results, one way TH could signal that and build some anticipation among investors for those results would be to note that Dr. Rothenberg will be participating on their 4Q and full year results conference call when they send out the press release announcing the date of the release and call. 

Of course, what they have to share might not justify his presence on the call but let's hope it does.
Comment by palinc2000 on Feb 09, 2022 11:51am
Dr Rothenberg is also a Board Member of Surrozen ,and Tngo THreapeutics ,and Aulos Science ,,, Aulos has what appears to be a very disruptive approach to treating cancer... While I think its great that he is advising THTX I think that coming to the conclusion that he came on board because  he sees certainty of  success in TH 1902 is far fetch....He is getting paid for his consulting ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities